AUS
NZ
UK
CA
USA
IND
Healthcare
ImmuPharma Stock Movement Updates and Biopharmaceutical
September 18, 2025 12:57 PM BST| By Vivek SinghImmuPharma (LON:IMM) develops peptide therapeutics, including Lupuzor™, for autoimmune diseases, with performance tracked within the FTSE AIM UK 50 INDEX.
ImmuPharma (LON:IMM) Shares Slide on AIM FTSE 100 Today Live
September 18, 2025 12:21 PM BST| By Vivek SinghImmuPharma plc (LON:IMM) on AIM saw substantial trading volume changes, highlighting its role within FTSE indices and its focus on peptide-based Lupus therapy.
Craneware Enhances FTSE AIM 100 Healthcare Technology
September 17, 2025 02:31 PM BST| By Vivek SinghCraneware (LSE:CRW) delivers structured operational updates, enhancing transparency, accountability, and FTSE AIM 100 healthcare sector representation in UK equity benchmarks.
FTSE 100 Hemogenyx Pharmaceuticals Stock Surges on Positive Market Momentum
September 16, 2025 03:02 PM BST| By Team Kalkine MediaHighlights,Hemogenyx Pharmaceuticals (LON:HEMO) experienced a strong upward movement during recent trading sessions.,Increased trading activity reflected growing investor attention toward the biotechnology sector.,The company continues to advance inn...
ImmuPharma (LON:IMM) Surges on FTSE AIM 100 Index Momentum
September 16, 2025 02:46 PM BST| By Team Kalkine MediaImmuPharma (LON:IMM) surged on the FTSE AIM 100 Index amid heavy trading, highlighting its Lupuzor™ peptide therapy focus and AIM market relevance.
Shield Therapeutics Market Activity and Healthcare Sector Performance
September 16, 2025 02:03 PM BST| By Vivek SinghShield Therapeutics (LSE:STX) market activity reflects corporate funding and operational updates in the healthcare sector, influencing trading trends across AIM and midcap stocks.
ImmuPharma Updates on Share Trading Activity
September 16, 2025 01:50 PM BST| By Vivek SinghImmuPharma (LSE:IMM), listed on the FTSE AIM 100 Index, issued a structured update on share trading, reinforcing governance in the healthcare and biotechnology sector.
Craneware Corporate Updates Reflect FTSE 350 Positioning
September 16, 2025 11:48 AM BST| By Vivek SinghCraneware, part of the FTSE 350 and FTSE All-Share, reports operational updates, maintaining structured visibility and transparency in the healthcare technology sector.
Craneware plc Gains Rating Amid Healthcare Technology Strength
September 16, 2025 10:40 AM BST| By Vivek SinghCraneware plc (LON:CRW) in healthcare technology gains renewed rating, reflecting its strong role among ftse 100 live today tracked companies.
Vistry Group Update FTSE 350 Infra and Real Estate Stocks Activity
September 15, 2025 07:39 PM BST| By Vivek SinghVistry Group (LSE:VTY) released earnings within the FTSE 350, reflecting real estate activity, housing supply updates, and its integration with multiple UK market sectors.
FTSE Aim 100 Index Movement Highlights ImmuPharma Trading Developments
September 15, 2025 07:39 PM BST| By Vivek SinghImmuPharma (LSE:IMM), listed in the FTSE Aim 100 Index, reflects the healthcare sector’s role in UK markets through pharmaceutical developments and market activity.
Hutchmed (LSE:HCM) Healthcare Focus within FTSE 350 Sector Dynamics
September 15, 2025 01:31 PM BST| By Vivek SinghHutchmed (LSE:HCM) highlights the role of Healthcare Stocks in the FTSE 350, with links to Technology, AI, Industrial, and Consumer sectors shaping operational efficiency.
Renalytix Collaboration Drives Healthcare Innovation with Advanced Diagnostics
September 15, 2025 10:50 AM BST| By Vivek SinghRenalytix (LSE:RENX) leverages AI and data-driven diagnostics, advancing patient stratification, predictive modeling, and precision medicine through strategic collaboration, strengthening healthcare technology positioning.
Craneware (LON:CRW) Shares Surge Beyond 200-Day Average on Indexftse-AIM1
September 15, 2025 09:28 AM BST| By Vivek SinghCraneware (LON:CRW) delivers automated healthcare financial and operational solutions, with shares above the 200-day moving average, listed on the FTSE AIM 100 Index.
Immupharma PLC Strengthens Position in FTSE AIM All Share with (LSE:IMM) Activity
September 15, 2025 07:43 AM BST| By Vivek SinghImmupharma PLC (LSE:IMM) continues its presence in the FTSE AIM All Share, representing healthcare stocks and reflecting market movements within its sector.
Haleon LSE:HLN Strengthens Position Across FTSE Healthcare Landscape
September 13, 2025 02:40 PM BST| By Vivek SinghHaleon (LSE:HLN) updates reinforce its healthcare sector role, reflecting consumer product strength and presence within blue-chip companies.
Animalcare Group Stock Movement Observed Below Key 200-Day Level
September 12, 2025 10:46 AM BST| By Vivek SinghAnimalcare Group (LON:ANCR) operates in the animal healthcare sector, with mid-cap FTSE 350 placement, recent 200-day moving average decline, and notable liquidity and volatility metrics.
ImmuPharma Jumps on FTSE AIM 100 Index Surge FTSE 100 Today Live
September 12, 2025 09:30 AM BST| By Vivek SinghImmuPharma LON:IMM, a peptide-focused biopharmaceutical in the FTSE AIM 100 Index, experienced notable trading activity, reflecting market attention on its autoimmune therapy pipeline.
Faron Pharmaceuticals Shares Dip Below Moving Average
September 11, 2025 12:04 PM BST| By Vivek SinghHighlights,Faron Pharmaceuticals Oy (LON:FARN) operates within the clinical-stage biopharmaceutical sector, developing treatments for significant medical needs.,The company’s stock moved below its 50-day moving average, with trading activity reflecti...
Venture Life Group Moves Above Key Average Amid FTSE350 Landscape
September 11, 2025 11:54 AM BST| By Vivek SinghHighlights,Venture Life Group operates in the global self-care sector, covering oral care, dermo-cosmetics, and medical devices.,The stock recently surpassed its 50-day moving average while remaining within FTSE350 listings.,Recent financial metrics...
